Lonhala Magnair Kit

Active Ingredient(s): Glycopyrrolate
FDA Approved: * December 5, 2017
Pharm Company: * SUNOVION RESP
Category: Lungs (Pulmonary)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Lonhala Magnair Kit Overview

Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has few to no central effects. It is available in oral, intravenous, topical, and inhaled forms. It is a synthetic quaternary ammonium compound. The cation, which is the active moiety, is called glycopyrronium (INN)[1] or glycopyrrolate (USAN). In June 2018, glycopyrronium was approved by the FDA to treat excessive underarm sweating,...

Read more Lonhala Magnair Kit Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Glycopyrrolate

Recent Lonhala Magnair Kit Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Glycopyrrolate or a similar ingredient: (12 results)

• CUVPOSA Glycopyrrolate
• GLYCOPYRROLATE 12 discussions
• GLYRX-PF Glycopyrrolate
• ROBINUL Glycopyrrolate1 discussion
• ROBINUL INJECTABLE Glycopyrrolate
• SEEBRI NEOHALER Glycopyrrolate
• BEVESPI AEROSPHERE Glycopyrrolate + Formoterol Fumarate1 discussion
• BREZTRI AEROSPHERE Budesonide + Formoterol Fumarate + Glycopyrrolate
• BUDESONIDE + FORMOTEROL FUMARATE + GLYCOPYRROLATE
• GLYCOPYRROLATE + FORMOTEROL FUMARATE
• INDACATEROL + GLYCOPYRROLATE
• UTIBRON NEOHALER Indacaterol + Glycopyrrolate

Related Lonhala Magnair Kit Topics: